Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells
Sidi Yang,1,2 Yufei Chen,1,2 Kaien Gu,1,2 Alicia Dash,1,2 Casey L Sayre,1 Neal M Davies,1 Emmanuel A Ho1,2 1Faculty of Pharmacy, 2Laboratory for Drug Delivery and Biomaterials, University of Manitoba, Winnipeg, MB, Canada Abstract: The goal of this study was to develop and characterize an intravagin...
Guardado en:
Autores principales: | Yang S, Chen Y, Gu K, Dash A, Sayre CL, Davies NM, Ho EA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b273b3d39514f8baa565e2d66c84ab6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanomedicine in pulmonary delivery
por: Heidi M Mansour, et al.
Publicado: (2009) -
Nanomedicine engulfed by macrophages for targeted tumor therapy
por: Li S, et al.
Publicado: (2016) -
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
por: Minfeng Huo, et al.
Publicado: (2017) -
Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems
por: Hajialyani M, et al.
Publicado: (2018) -
Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems
por: Jiang Z, et al.
Publicado: (2012)